Last reviewed · How we verify
NCT03664596
Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis
NA trial testing Sublimated mare's milk in Non-alcoholic Steatohepatitis in 80 participants. Completed in 1 December 2020.
1 September 2020
Quick facts
| Lead sponsor | Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 August 2018 |
| Primary completion | 1 September 2020 |
| Estimated completion | 1 December 2020 |
| Sites | 1 location across Kazakhstan |
Drugs / interventions tested
- Sublimated mare's milk
- Ursodeoxycholic Acid — full drug profile →
Conditions studied
- Non-alcoholic Steatohepatitis — all drugs for Non-alcoholic Steatohepatitis →
Sponsor
Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan
Who can join
Adults 16 to 60, any sex, with Non-alcoholic Steatohepatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the dietary and therapeutic effect of supplement consisting of sublimated mare milk among patients with non-alcoholic steatohepatitis.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.
Kim MJ, Jeon JH. · · 2022 · cited 60× · PMID 35269986 · DOI 10.3390/ijms23052846 -
Addressing the heterogeneity in liver diseases using biological networks.
Lam S, Doran S, Yuksel HH, Altay O, et al · · 2021 · cited 5× · PMID 32201876 · DOI 10.1093/bib/bbaa002
Verify or expand the search:
- PubMed search for NCT03664596
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Non-alcoholic Steatohepatitis
Currently open trials in the same condition.
- NCT05945537 — A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH · Phase 1 · recruiting
- NCT05462353 — Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH · Phase 2 · active not recruiting
- NCT05573204 — Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis · Phase 2 · active not recruiting
- NCT04822181 — Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) · Phase 3 · active not recruiting
- NCT04666402 — Integrated Diagnostics for Early Diagnosis of Liver Disease · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03664596 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan
- Last refreshed: 5 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03664596.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing